Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc C Chamberlain

Showing results (31-40 of 244) with videos related to

Pageof 25
Sort By:
Oncology (Williston Park, N.Y.)|May 17, 2015
Treatment of meningioma, including in cases with no further surgical or radiotherapy optionsMarc C Chamberlain
The Neurologist|July 13, 2006
Neoplastic meningitisMarc C Chamberlain
Neuro-Oncology|May 12, 2011
Convection-enhanced delivery of a transforming growth factor-beta2 inhibitor trabedersen for recurrent high-grade gliomas: efficacy real or imagined?, in reference to Bogdahn et al. (Neuro-Oncology 2011;13:132-142)Marc C Chamberlain
Clinical Advances in Hematology & Oncology : H&O|June 21, 2011
Lymphomatous meningitis as a presentation of non-Hodgkin lymphomaMarc C Chamberlain
Handbook of Clinical Neurology|January 11, 2012
Neoplastic meningitisMarc C Chamberlain
Neurology|August 24, 2011
The paradoxical effect of bevacizumab in the therapy of malignant gliomasMarc C Chamberlain
Nature Clinical Practice. Oncology|January 13, 2006
Are EGFR antagonists associated with increased central nervous system metastases in non-small-cell lung cancer?Marc C Chamberlain
Cancer Treatment and Research|December 15, 2007
Chemotherapy for brain metastases due to lung cancer and melanomaMarc C Chamberlain
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2005
Mafosfamide: a new intra-CSF chemotherapy?Marc C Chamberlain
The Neurologist|January 13, 2010
10 Questions about the use of bevacizumab in the management of recurrent malignant gliomasMarc C Chamberlain
Pageof 25

Showing results (31-40 of 244) with videos related to

Sort By:
Pageof 25
Oncology (Williston Park, N.Y.)|May 17, 2015
Treatment of meningioma, including in cases with no further surgical or radiotherapy optionsMarc C Chamberlain
The Neurologist|July 13, 2006
Neoplastic meningitisMarc C Chamberlain
Neuro-Oncology|May 12, 2011
Convection-enhanced delivery of a transforming growth factor-beta2 inhibitor trabedersen for recurrent high-grade gliomas: efficacy real or imagined?, in reference to Bogdahn et al. (Neuro-Oncology 2011;13:132-142)Marc C Chamberlain
Clinical Advances in Hematology & Oncology : H&O|June 21, 2011
Lymphomatous meningitis as a presentation of non-Hodgkin lymphomaMarc C Chamberlain
Handbook of Clinical Neurology|January 11, 2012
Neoplastic meningitisMarc C Chamberlain
Neurology|August 24, 2011
The paradoxical effect of bevacizumab in the therapy of malignant gliomasMarc C Chamberlain
Nature Clinical Practice. Oncology|January 13, 2006
Are EGFR antagonists associated with increased central nervous system metastases in non-small-cell lung cancer?Marc C Chamberlain
Cancer Treatment and Research|December 15, 2007
Chemotherapy for brain metastases due to lung cancer and melanomaMarc C Chamberlain
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2005
Mafosfamide: a new intra-CSF chemotherapy?Marc C Chamberlain
The Neurologist|January 13, 2010
10 Questions about the use of bevacizumab in the management of recurrent malignant gliomasMarc C Chamberlain
Pageof 25